[1]Kharbanda,Anupreet;Tran,Phuc;Zhang,Lingtian;Leung,Yuet-Kin;Li,Hong-yu;Frett,Brendan[EuropeanJournalofMedicinalChemistry,2021,vol.225]
1776066-28-4
118767-86-5
6714-29-0
116529-62-5 | 4-iodo-2-nitrobenzoic acid | AA000CMQ | MFCD09909618
1167414-88-1 | (R)-1-M-Tolylethanamine-hcl | AA000D34 | MFCD11101211
1170019-97-2 | 3-(N-Boc-methylaminomethyl)azetidine HCl | AA000DG3 | MFCD09998721
117175-41-4 | (R)-tert-Butyl 2-carbamothioylpyrrolidine-1-carboxylate | AA000DRZ | MFCD06738836
117309-46-3 | Benzeneacetic acid, α-[[(4-methoxyphenyl)sulfonyl]amino]-, (S)- (9CI) | AA000E11 | MFCD00172801
114468-04-1 | 3-Bromo-5-(difluoromethyl)pyridine | AA000EDP | MFCD18393708
1147222-53-4 | 1H-Pyrazol-4-amine, 1-[(2-chloro-4-fluorophenyl)methyl]-, hydrochloride (1:1) | AA000F15 | MFCD04967257
114960-98-4 | 4-(1-Azepanyl)-1-butanol | AA000FFE | MFCD03211285
1150164-70-7 | Methyl 1-(5-bromopyridin-2-yl)-5-(2-chlorophenyl)pyrazole-4-carboxylate | AA000FLU | MFCD11855922
1150654-77-5 | 1,3-Dimethyluracil-5-trifluoroborate potassium salt | AA000FRY | MFCD09271782